Axsome Therapeutics, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Industry & Market
No industry information available
Funding Information
No funding information available
Headcount Distribution
No headcount data available
Department Breakdown
No department data available
Keywords & Focus Areas
No keywords available
Overview
Axsome Therapeutics, Inc. is a biopharmaceutical company based in New York, founded in January 2012 by Dr. Herriot Tabuteau, Chairman and CEO. The organization specializes in developing and commercializing innovative therapies for central nervous system (CNS) disorders with limited treatment options. Axsome advances drug candidates through clinical trials and regulatory approvals to address unmet needs in the CNS landscape.
The company has reached significant milestones, including its initial public offering in 2015, positive Phase 3 results for AXS-05 in 2019, and the FDA approval of Auvelity™ in 2022 for major depressive disorder. In 2023, Axsome launched Auvelity™, generating $130.1 million in net product revenue, along with $65.7 million from its Sunosi product. Ongoing development efforts target a wide range of CNS conditions.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to
Compare insights from companies similar to , focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxxx | $61775 | 59 | Private | - | 3062 | xxxxxxx |
| xxxxxxxxxx | $58948 | 128 | Private | - | 8574 | xxx |
| xxxxxxxxx | $34533 | 128 | Private | - | 3199 | xxxxxxx |
| xxx | $66766 | 148 | Private | - | 5484 | xxxxxx |
| xx | $46657 | 34 | Private | - | 2742 | xxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.